Dallas 11/2/2010 9:31:05 PM
News / Stocks

OTCPicks.com Announces Initiation of Profile Coverage Spencer Pharmaceutical Inc. (OTC: SPPH)

OTCPicks.com, announced today that it has initiated Profile Coverage of Spencer Pharmaceutical Inc. (OTC: SPPH).

OTCPicks.com, announced today that it has initiated Profile Coverage of Spencer Pharmaceutical Inc. (OTC: SPPH). Spencer Pharmaceuticals Inc. is a public company specializing in the identification of new drug delivery applications. Spencer Pharmaceutical Inc. recently announced that it has signed a preliminary cooperative development agreement with National Pharmaceutical Corp.

To view the OTCPicks.com Company Profile for Spencer Pharmaceutical Inc. (OTC: SPPH)

, CLICK HERE

Company Overview

Spencer Pharmaceuticals Inc. (Pinksheets: SPPH) is a public company specializing in the identification of new drug delivery applications. A global player in the biopharmaceutical market, Spencer has forged relationships with two highly respected laboratories located in Universities throughout the world. Their focus is on newly patented formulation of existing drugs from the incubation to the developmental stages or newly synthesized drugs able to cross the blood-brain barrier. The company's partners are experienced researchers providing years of research, now ready for the drug-development status.

Spencer is currently focusing on the development of 2 patented applications (ready for Human trial) in the treatment of Central Nervous System diseases and of Diabetes:

> L’Institut National des Sciences Appliquées de Rouen (INSA Rouen) has discovered a new technology in the challenging area of drugs delivered to the Central Nervous System through an innovative approach that allows the crossing of the blood-brain barrier and dramatically reducing the side effects of drugs used for neurological diseases.

> L’Universite du Québec à Montréal (UQAM) has discovered how to control the release of existing therapeutics molecules in order to increase their bio-availability and systemic efficacy.

The company's goal is to develop a portfolio of pro-drugs with the ability to outclass the current commercial drugs.

About OTCPicks.com

OTCPicks.com is an Internet destination for investors seeking information on small cap and micro cap companies. The web site features companies in Profile Campaigns, Executive Interviews and Research Reports authored by our financial writers. We publish our Daily Market Movers Digest Newsletter to opt-in investor members. To feature a company on OTCPicks.com, please contact our publisher at 972-546-3740, or via email at publisher@otcpicks.com.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: OTCPicks and affiliates have been compensated ten thousand dollars by a third party (IAB Media) for SPPH advertising and promotional services.

OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk.